Hyaluronan and its derivatives for ophthalmology: Recent advances and future perspectives
Language English Country Great Britain, England Media print-electronic
Document type Journal Article, Review
PubMed
33673986
DOI
10.1016/j.carbpol.2021.117697
PII: S0144-8617(21)00084-9
Knihovny.cz E-resources
- Keywords
- Amphiphilic derivatives, Complexation, Dry eye disease, Hyaluronan, Medical devices, Ophthalmology,
- MeSH
- Glaucoma drug therapy MeSH
- Hyaluronic Acid analogs & derivatives therapeutic use MeSH
- Humans MeSH
- Drug Carriers chemistry MeSH
- Eye Diseases drug therapy MeSH
- Ophthalmic Solutions chemistry MeSH
- Antineoplastic Agents chemistry metabolism MeSH
- Viscosity MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Review MeSH
- Names of Substances
- Hyaluronic Acid MeSH
- Drug Carriers MeSH
- Ophthalmic Solutions MeSH
- Antineoplastic Agents MeSH
Ophthalmic disorders are amid the most common pathologies worldwide. In this regard, hyaluronan (HA) has gained widespread use in eye surgeries and treatment of eye diseases. HA-based materials are well tolerated and show excellent biocompatibility. Therefore, HA is a sought-after component of ophthalmic formulations. However, several parameters have to be adjusted to reach an optimal performance and effectiveness. The complexity of HA properties represents a major challenge for biological and structural characterization. This review covers fundamental aspects and recent developments in HA ophthalmic research. Biological mechanisms underlying the health benefits of HA and their potential therapeutic applications are elaborated. Furthermore, current pharmacokinetic and safety studies are discussed. Noticeably, the benefits of chemical modification and processed HA forms are described to broaden the applications of this unique polysaccharide. The current research challenges and prospects are also outlined and discussed.
References provided by Crossref.org
